Joslyn Sciacca-Kirby, MD
Dermatology · Hershey, PANPI 1821158767
Payments from drug & device makers
Across 475 payments — averaging $2815.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$574K
- AbbVie$346K
- UCB SA$217K
- Novartis$52K
- Gilead$37K
- UCB, Inc.$24K
- plus $88K from 16 others
Across 14 payments — averaging $2329.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$22K
- UCB, Inc.$11K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 88 | $573,593 |
| AbbVie | 234 | $345,702 |
| UCB SA | 31 | $217,280 |
| Novartis | 37 | $52,286 |
| Gilead | 12 | $36,933 |
| UCB, Inc. | 12 | $23,587 |
| Pfizer | 10 | $23,364 |
| Janssen Research & Development, LLC | 7 | $16,122 |
| Sun Pharmaceutical Industries Inc. | 16 | $12,444 |
| Insmed, Inc. | 4 | $6,322 |
| Janssen Scientific Affairs, LLC | 2 | $6,128 |
| Novartis Pharma AG | 3 | $6,050 |
| Amgen | 1 | $6,000 |
| Janssen Global Services, LLC | 5 | $5,344 |
| Almirall LLC | 4 | $2,980 |
| UCB Biosciences Inc. | 2 | $2,220 |
| CSL Behring | 1 | $650 |
| Journey Medical Corporation | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $100 |
| Sanofi | 1 | $60 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Boehringer Ingelheim | 1 | $17 |
How this compares
$1,337,360 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Hershey
- Jeffrey MillerHershey$469K
- Andrea ZaengleinHershey$392K
- Lauren HollinsHershey$84K
- Victoria WerthPhiladelphia$7.2M
- Laura FerrisPittsburgh$4.3M
- Joel GelfandPhiladelphia$3.6M
- Scott GottliebExton$3.4M
- Lawrence ParishPhiladelphia$2.9M
- Stephen SchleicherSugarloaf$2.3M
- Douglas KressWexford$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.